跳至主要内容
临床试验/CTRI/2013/04/003544
CTRI/2013/04/003544招募中1 期

EFFECT OF KALA PRAKARSHA ON PHARMACEUTICAL PROCESSING W.S.R. BHALLATAKA AND ITS EFFICACY ON TYPE II DIABETES MELLITUS

IPGT and RA0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients having fasting blood sugar level>=126mg/dl or 2hrs.
  • Post prandial glucose level>=200mg/dl up to 600mg/dl

排除标准

  • (A) Patients of Diabetes mellitus receiving Insulin.
  • (B) Patients having chronic complications of Diabetes mellitus
  • a.Microvascular: Retinopathy, Neuropathy and Nephropathy.
  • b.Macrovascular: Coronary artery disease, Peripheral vascular disease & Cerebro-vascular disease.
  • c.Other chronic debilitating disease like STD etc.
  • (C) Pitta-Adhikya, Garbhini, Vimukta Raktatva, Trisna, Mukha Shosha, Anatamvana, Aalsi, Pramadi, Vyasani, Bhesajapmani.

研究者

发起方
IPGT and RA

相似试验